| Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition LE Stopfer, JM Mesfin, BA Joughin, DA Lauffenburger, FM White Nature Communications 11 (1), 2760, 2020 | 75 | 2020 |
| Apoptotic bodies elicit Gas6-mediated migration of AXL-expressing tumor cells AJM Zweemer, CB French, J Mesfin, S Gordonov, AS Meyer, ... Molecular Cancer Research 15 (12), 1656-1666, 2017 | 34 | 2017 |
| Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues MT Spang, R Middleton, M Diaz, J Hunter, J Mesfin, A Banka, H Sullivan, ... Nature biomedical engineering 7 (2), 94-109, 2023 | 19 | 2023 |
| Single-cell and spatial transcriptomics of the infarcted heart define the dynamic onset of the border zone in response to mechanical destabilization DM Calcagno, N Taghdiri, VK Ninh, JM Mesfin, A Toomu, R Sehgal, J Lee, ... Nature Cardiovascular Research 1 (11), 1039-1055, 2022 | 17 | 2022 |
| Myocardial matrix hydrogel acts as a reactive oxygen species scavenger and supports a proliferative microenvironment for cardiomyocytes RM Wang, JM Mesfin, J Hunter, P Cattaneo, N Guimarães-Camboa, ... Acta Biomaterialia 152, 47-59, 2022 | 13 | 2022 |
| MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas LE Stopfer, NJ Rettko, O Leddy, JM Mesfin, E Brown, S Winski, B Bryson, ... Proceedings of the National Academy of Sciences 119 (49), e2208900119, 2022 | 9 | 2022 |
| Inflammation-responsive micellar nanoparticles from degradable polyphosphoramidates for targeted delivery to myocardial infarction Y Liang, HL Sullivan, K Carrow, JM Mesfin, J Korpanty, K Worthington, ... Journal of the American Chemical Society 145 (20), 11185-11194, 2023 | 8 | 2023 |
| Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins TB Fessenden, LE Stopfer, F Chatterjee, J Zulueta, J Mesfin, TC Dumit, ... Journal for ImmunoTherapy of Cancer 10 (7), 2022 | 8 | 2022 |
| Immunomodulatory contribution of mast cells to the regenerative biomaterial microenvironment RM Wang, JM Mesfin, M Karkanitsa, JL Ungerleider, E Zelus, Y Zhang, ... NPJ Regenerative Medicine 8 (1), 53, 2023 | 5 | 2023 |
| Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction A Chen, JM Mesfin, NC Gianneschi, KL Christman Advanced Materials, 2300603, 2023 | 3 | 2023 |
| Myocardial matrix hydrogels mitigate negative remodeling and improve function in right heart failure model JD Hunter, JM Mesfin, T Ahmed, A Chen, K Reimold, A Hancko, ... Basic to Translational Science 9 (3), 322-338, 2024 | 1 | 2024 |
| Healing Tissues From the Inside Out: Infusible Biomaterial for Targeting and Treating Inflammatory Tissues via Intravascular Administration MT Spang, R Middleton, M Diaz, R Wang, J Hunter, J Mesfin, TS Lazerson, ... biorxiv, 2020.04. 10.028076, 2020 | 1 | 2020 |
| Biomaterials for Pro-Reparative Remodeling in Myocardial Infarction JM Mesfin UC San Diego, 2024 | | 2024 |
| An Infusible Extracellular Matrix Biomaterial Improves Survival in a Model of Severe Systemic Inflammation ML Karkanitsa, R Wang, AC Lyons, JM Mesfin, A Chen, MT Spang, ... bioRxiv, 2024.06. 05.597616, 2024 | | 2024 |
| Single Nuclei Analyses Depict Cardiac Preservation Mechanisms Behind Administering Myocardial Matrices J Mesfin, M Diaz, V Ninh, M Karkanitsa, E Wong, R Braden, C Luo, K King, ... TISSUE ENGINEERING PART A 29 (9-10), 2023 | | 2023 |
